Bridgeway Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bridgeway Capital Management’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-112,000	Closed	-$19.6K	–	1435
2023 Q3	$19.6K	Hold	112,000	–	–	﹤0.01%	1342
2023 Q2	$349K	Buy	112,000 +25,000	+29%	+$74.4K	0.01%	1004
2023 Q1	$223K	Sell	87,000 -100,000	-53%	-$206K	0.01%	1085
2022 Q4	$279K	Hold	187,000	–	–	0.01%	1006
2022 Q3	$325K	Hold	187,000	–	–	0.01%	1014
2022 Q2	$243K	Buy	187,000 +40,000	+27%	+$68.5K	0.01%	1050
2022 Q1	$350K	Buy	147,000 +100,000	+213%	+$261K	0.01%	1030
2021 Q4	$216K	Sell	47,000 -66,800	-59%	-$221K	﹤0.01%	1153
2021 Q3	$922K	Buy	113,800 +3,800	+3%	+$32.6K	0.02%	850
2021 Q2	$1.08M	Buy	110,000 +20,000	+22%	+$163K	0.02%	833
2021 Q1	$794K	Buy	+90,000	New	+$988K	0.01%	944

Other funds holding GRTX

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bridgeway Capital Management's GRTX Position: Q4 2023 in Review

Bridgeway Capital Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2023, closing a stake of 112,000 shares — an estimated $19.6K sold.

Bridgeway Capital Management first reported a position in GRTX in Q1 2021 and held it in 11 quarters. The position peaked at $1.08M in Q2 2021. 37 funds tracked by Wall St. Rank hold GRTX as of Q4 2023.

Bridgeway Capital Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bridgeway Capital Management sold 112,000 Galera Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $19.6K.
Bridgeway Capital Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Bridgeway Capital Management's Galera Therapeutics, Inc. Common Stock position peaked at $1.08M in Q2 2021.
37 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.